Global Dermatological Drugs Market worth USD 56.65 Billion by 2033 | CAGR of 10.07%
Category: HealthcareGlobal Dermatological Drugs Market worth USD 56.65 Billion by 2033
According to a research report published by Spherical Insights & Consulting, the Global Dermatological Drugs Market Size is Expected to Grow from USD 21.71 Billion in 2023 to USD 56.65 Billion by 2033, at a CAGR of 10.07% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 235 pages with 110 Market data tables and figures & charts from the report on the" Global Dermatological Drugs Market Size, Share, and COVID-19 Impact Analysis, By Type (Prescription and Over-the-counter (OTC)), By Therapy (Acne, Psoriasis, Rosacea, Alopecia, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/dermatological-drugs-market
The diagnosis, treatment, and prevention of a wide range of skin-related conditions, including those affecting the hair and nails, are the main goals of the medical speciality known as dermatology. Dermatological medicines are medications used in the treatment of skin problems. The main goal of dermatological drugs is to avoid skin issues. To preserve skin qualities like radiance and health, dermatological medications are also used in the skincare sector. The demand for innovative treatments most likely rise globally as the number of patients with vitiligo, dermatitis, and acne increases. Increased spending on personal care, increased awareness of skin conditions, a rise in the number of patients with vitiligo, dermatitis, and acne, a rise in the demand for dermatological treatments with a high level of awareness among young people, and an increase in the number of companies investing in the market are all major factors driving the market's growth. However, the usage of products to treat dermatological ailments has decreased in low- and middle-income countries due to a lack of awareness about skin problems and a higher rate of illiteracy. Market expansion is also hindered by the negative effects associated with the products.
The prescription segment is predicted to hold the largest market share through the forecast period.
Based on the type, the dermatological drugs market is classified into prescription and over-the-counter (OTC). Among these, the prescription segment is predicted to hold the largest market share through the forecast period. Prescriptions are on the rise in the market as patients can more easily acquire treatments due to better access to healthcare and the availability of pharmaceuticals.
The psoriasis segment is anticipated to hold the highest market share during the projected timeframe.
Based on the therapy, the dermatological drugs market is divided into acne, psoriasis, rosacea, alopecia, and others. Among these, the psoriasis segment is anticipated to hold the highest market share during the projected timeframe. It comprises VTAMA cream, a non-steroidal therapy authorized for severe plaque psoriasis in adults. For patients with skin conditions, the treatment works well.
The retail pharmacies segment is anticipated to hold the largest market share during the projected timeframe.
Based on the distribution channel, the dermatological drugs market is divided into hospital pharmacies, retail pharmacies, and others. Among these, the retail pharmacies segment is anticipated to hold the largest market share during the projected timeframe. OTC dermatological product increase and skin problem awareness are responsible for driving the dermatological drugs market in the retail pharmacies segment.
North America is estimated to hold the largest share of the dermatological drugs market over the forecast period.
Get more details on this report -
North America is estimated to hold the largest share of the dermatological drugs market over the forecast period. The United States of America is contributing significantly to the regional market growth. One of the most important elements influencing the expansion of the pharmaceutical business is the existence of several reliable suppliers.
Asia Pacific is predicted to grow at the highest CAGR growth in the dermatological drugs market over the forecast period. A large number of people suffer from skin diseases in the world's most populated countries, including China and India. Further, the presence of better healthcare infrastructure and awareness of skin diseases in the region are propelling the market growth.
Major key players in the dermatological drugs market include Johnson & Johnson Services, Inc., Sun Pharmaceutical, Almirall, S.A, Eli Lilly and Company, Pfizer Inc., GALDERMA, Amgen Inc., GSK plc., Novartis AG, AbbVie Inc., Bausch Health Companies Inc., and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In January 2024, In India, Pfizer Inc. and Glenmark Pharmaceuticals collaborated to launch abrocitinib, often referred to as CIBINQO, an oral medication for atopic dermatitis. For individuals with this chronic skin problem, this medication offers quick relief from itching and long-term disease control.
Market Segment
- This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the dermatological drugs market based on the below-mentioned segments:
Global Dermatological Drugs Market, By Type
- Prescription
- Over-the-counter (OTC)
Global Dermatological Drugs Market, By Therapy
- Acne
- Psoriasis
- Rosacea
- Alopecia
- Others
Global Dermatological Drugs Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
Global Dermatological Drugs Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?